CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 680 enrolled
Drug / intervention
Nasotracheal intubationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05433155
NCT05433155N/ACompleted

Nasotracheal Intubation With Videolaryngoscopy Versus Direct Laryngoscopy in Infants (NasoVISI) Trial

Children's Hospital of Philadelphia·interventional·Posted Jun 27, 2022·Updated Mar 28, 2025

In Brief

A clinical study evaluating Nasotracheal intubation for Intubation Complication and 5 related conditions. Completed, enrolled 680 participants across 8 sites.

Detailed Summary

Nasotracheal Intubation with Videolaryngoscopy versus Direct Laryngoscopy in Infants (NasoVISI) Trial is a prospective randomized multicenter study. The study will be conducted at 8 centers in the United States. It is expected that approximately 700 subjects enrolled to product 670 evaluable subjects.The randomization is 1:1 naso tracheal intubation with the Storz C-Mac Video Videolaryngoscopy (VL) or the Standard Direct Laryngoscope (DL). The primary objective is to compare the nasotracheal intubation (NTI) first attempt success rate using VL vs. DL in infants 0-365 days of age presenting for cardiothoracic surgery and cardiac catheterizations.

Study Details

Timeline

N/ACompletedFinished
2023202420252026
First PostedJun 27, 2022
Enrollment StartJun 6, 2022
Primary CompletionFeb 25, 2025
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 4.0 years ago

Interventions

Nasotracheal intubationdevice

Nontracheal intubation using clinical standard videolaryngoscopy or direct laryngoscopy